- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Shandong Tumor Hospital
Total 1155 results
-
Shandong First Medical UniversityShandong Tumor HospitalCompletedRecurrent Childhood Rhabdomyosarcoma | Alveolar Childhood Rhabdomyosarcoma | Embryonal Childhood RhabdomyosarcomaChina
-
Suzhou Genhouse Bio Co., Ltd.Shanghai East Hospital; Shandong Tumor HospitalRecruitingAdvanced Solid Tumors With MAPK Signal Pathway MutantChina
-
Peking UniversityPeking University International Hospital; Jiangxi Provincial Cancer Hospital; Shandong Tumor HospitalUnknownExperimental TumorChina
-
Anyang Tumor HospitalUnknownEsophagogastric Junction CancerChina
-
Hebei Tumor HospitalUnknown
-
Hebei Tumor HospitalUnknown
-
Hebei Tumor HospitalUnknown
-
Hebei Tumor HospitalUnknown
-
Shandong Provincial HospitalShandong UniversityCompleted
-
Shandong Provincial HospitalShandong UniversityCompletedThyroid CancerChina
-
Shandong Provincial HospitalShandong UniversityCompleted
-
Shandong UniversityShandong Provincial HospitalRecruitingEarly-Onset Neonatal SepsisChina
-
Shandong UniversityShandong Provincial HospitalRecruiting
-
Shandong Provincial HospitalShandong UniversityCompleted
-
Hunan Province Tumor HospitalNot yet recruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalNot yet recruitingNon-Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalNot yet recruiting
-
Hunan Province Tumor HospitalRecruitingAdvanced Lung CancerChina
-
Hunan Province Tumor HospitalRecruiting
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingLung Adenocarcinoma | ALK Gene Mutation | ImmunotherapyChina
-
Liaoning Tumor Hospital & InstituteNot yet recruiting
-
Liaoning Tumor Hospital & InstituteNot yet recruitingNSCLC | EGF-R Positive Non-Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruiting
-
Hunan Province Tumor HospitalRecruitingSmall-cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Liaoning Tumor Hospital & InstituteCompletedHER2-positive Metastatic Breast CancerChina
-
Hunan Province Tumor HospitalCompletedNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompleted
-
Hunan Province Tumor HospitalCompletedNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompleted
-
Hunan Province Tumor HospitalCompletedCarcinoma, Non-small Cell LungChina
-
Hunan Province Tumor HospitalCompletedNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompletedUncommon Pathological Types of Lung CancerChina
-
Liaoning Tumor Hospital & InstituteUnknown
-
Hunan Province Tumor HospitalCompletedNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage IIChina
-
Jilin Provincial Tumor HospitalUnknown
-
Liaoning Tumor Hospital & InstituteNot yet recruitingNon Small Cell Lung Cancer
-
Hunan Province Tumor HospitalRecruiting
-
Hunan Province Tumor HospitalRecruitingAdvanced Solid Tumors or LymphomasChina
-
Hunan Province Tumor HospitalRecruitingExtensive-stage Small-cell Lung CancerChina
-
Hunan Province Tumor HospitalNot yet recruiting
-
Liaoning Tumor Hospital & InstituteNot yet recruitingDiffuse Large B Cell LymphomaChina